Cencora (NYSE:COR) underwent analysis by 6 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish. The following table summarizes their recent ratings, shedding ...

Cencora Inc. closed 7.12% below its 52-week high of $262.26, which the company reached on February 5th. Supported by world-class markets data from Dow Jones and FactSet, and partnering with ...

Walgreens Boots Alliance has sold more shares of drug distributor Cencora for proceeds of about $300 million, “primarily for debt paydown and general corporate purposes,” the company said ...

Black Kite’s 6th annual Third Party Breach Report reveals that healthcare organizations, responsible for 41.2% of third-party ...

CONSHOHOCKEN, Pa. — CONSHOHOCKEN, Pa. — Cencora, Inc. (COR) on Wednesday reported fiscal first-quarter net income of $488.6 million. The Conshohocken, Pennsylvania-based company said it had ...

Analysts, on average, were expecting a forecast of $15.28 per share, according to data compiled by LSEG. Cencora beat first-quarter profit estimates due to strong sales in its U.S. healthcare ...

Cencora Inc. closed 3.71% short of its 52-week high of $261.25, which the company reached on January 30th. Supported by world-class markets data from Dow Jones and FactSet, and partnering with ...